MEDA acquires Rottapharm for about $3 Billion

MEDA acquires Rottapharm for about $3 Billion

Swedish drug maker Meda agrees to acquire Rottapharm, that operates under the name Rottapharm | Madaus in cash and stock deal for $3 Billion. (€ 2.275 Billion) Rottapharm, founded in 1961, is the maker of Dona, which is used to manage pain associated with osteoarthritis; Legalon, a treatment for liver disorders; and Reparil, an anti-inflammatory…

Read More...

AstraZeneca acquries Almirall Drugs for $2.1 Billion

AstraZeneca acquries Almirall Drugs for $2.1 Billion

The UK drugmaker AstraZeneca , after failed Pfizer Inc. takeover attempt, buys Almirall Drugs for $2.1 Billion. “Our agreement with Almirall brings strategic and long-term value to AstraZeneca’s strong respiratory franchise, one of our key growth platforms,” said Pascal Soriot, CEO of AstraZeneca. AstraZeneca will make additional payments – $875 million for drugs including Eklira,…

Read More...

IAC acquires the Princeton Review

IAC acquires the Princeton Review

The Princeton Review is a test preparation and college admission services company offering test preapartion services, tutoring and admissions resources, online courses, and books published by Random House. “We’re confident that by combining Tutor.com’s technology and marketing expertise with such a trusted brand, our A-to-Z solution for students will be like nothing else in the…

Read More...

Klépierre acquires Corio for $9.7 Billion

Klépierre acquires Corio for $9.7 Billion

Klépierre of Frence agreed to acqurie Corio in all stock deal for €7.2 Billion ($9.7 Billion). Klépierre’s largest shareholder The Simon Property Group and BNP Paribas and the Dutch pension fund manager APG, Corio’s largest shareholder, have agreed to support the transaction, the companies said. APG also has agreed to tender without appeal its 30.6…

Read More...